LAVA THERAPEUTICS NV (LVTX) Stock Balance Sheet
USA - NASDAQ:LVTX - NL0015000AG6 - Common Stock
1.7 USD
+0.1 (+6.25%)
1.7 USD
0 (0%)
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | 33.91M | 90.40M | 14.40M | |||
| Cash Equivalents | 39.67M | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 26.88M | null | 61.67M | 42.50M | 118.80M | |||
| Receivables | null | null | 1.70M | 3.30M | 700.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 3.22M | 2.72M | 3.33M | 4.40M | 2.60M | |||
| Total Current Assets | 69.78M | 79.00M | 99.00M | 140.50M | 136.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.28M | 1.44M | 2.46M | 2.10M | 1.90M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 95.00K | 90.00K | 320.00K | 800.00K | 800.00K | |||
| Total Non-Current Assets | 1.38M | 2.00M | 3.00M | 2.90M | 2.70M | |||
| TOTAL ASSETS | 71.16M | 81.00M | 102.00M | 143.40M | 139.20M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 4.89M | 5.28M | 4.60M | 0 | |||
| Current Portion Of LT Debt. | null | null | 440.00K | 400.00K | 300.00K | |||
| Accrued Expenses | 7.19M | 10.00M | 5.17M | 7.80M | 1.60M | |||
| Accounts Payable | 1.52M | 2.72M | 4.45M | 4.00M | 2.60M | |||
| Other Current Liabilities | 1.66M | null | 482.00K | 5.10M | 6.90M | |||
| Total Current Liabilities | 10.37M | 18.00M | 15.00M | 22.00M | 11.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 400.00K | 4.60M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 35.01M | 35.00M | 35.00M | 35.00M | 5.00M | |||
| Total Non-Current Liabilities | 35.01M | 35.00M | 35.00M | 35.40M | 9.70M | |||
| TOTAL LIABILITIES | 45.37M | 53.00M | 50.00M | 57.40M | 20.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -178.45M | -175.00M | -150.00M | -99.10M | -73.50M | |||
| Additional Paid In Capital | 212.20M | 212.00M | 208.00M | 194.40M | 192.30M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 3.72M | 3.72M | 3.72M | 3.70M | 3.70M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -11.68M | -13.00M | -11.00M | -13.00M | -4.00M | |||
| Shares Outstanding | 26.31M | 26.00M | 26.00M | 26.30M | 25.80M | |||
| Tangible Book Value per Share | 0.9802 | null | 1.9467 | 3.27 | 4.5891 | |||
| Total Shareholders' Equity | 25.78M | 28.00M | 51.00M | 86.00M | 118.40M | |||
| TOTAL LIABILITIES AND EQUITY | 71.16M | 81.00M | 102.00M | 143.40M | 139.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.06 | 0.04 | |||
| Current Ratio | 6.73 | 4.39 | 6.60 | 6.39 | 12.19 | |||
| Return On Assets (ROA) | -69.12% | -31.00% | -41.05% | -22.25% | -32.58% | |||
| Return On Equity (ROE) | -190.76% | -89.69% | -82.10% | -37.10% | -38.30% | |||
All data in USD , ROIC based on taxRate of 0.21